445 results on '"Strecker, Thomas"'
Search Results
2. Familial acute aortic dissection associated with a novel ACTA2 germline variant
3. Structural conservation of Lassa virus glycoproteins and recognition by neutralizing antibodies
4. The proprotein convertase SKI-1/S1P is a critical host factor for Nairobi sheep disease virus infectivity
5. Hexestrol, an estrogen receptor agonist, inhibits Lassa virus entry
6. Lassa virus glycoprotein nanoparticles elicit neutralizing antibody responses and protection
7. Design of a processing-head for AI-optimized welding and cutting
8. Rvsv-Zebov Vaccination in People with Pre-Existing Immunity to Ebolavirus: An Open-Label Safety and Immunogenicity Study in Guinean Communities Affected by Ebola Virus Disease (L’Essai Proches)
9. Longitudinal antibody and T cell responses in Ebola virus disease survivors and contacts: an observational cohort study
10. Defining bottlenecks and opportunities for Lassa virus neutralization by structural profiling of vaccine-induced polyclonal antibody responses
11. Serological Evidence for the Circulation of Ebolaviruses in Pigs From Sierra Leone
12. Ebola Virus Neutralizing Antibodies in Dogs from Sierra Leone, 2017
13. Early transmission and case fatality of Ebola virus at the index site of the 2013–16 west African Ebola outbreak: a cross-sectional seroprevalence survey
14. Structure of the Lassa virus glycan shield provides a model for immunological resistance
15. Pseudotyping of VSV with Ebola virus glycoprotein is superior to HIV-1 for the assessment of neutralising antibodies
16. Adjuvant formulated virus-like particles expressing native-like forms of the Lassa virus envelope surface glycoprotein are immunogenic and induce antibodies with broadly neutralizing activity
17. Favipiravir and Ribavirin Treatment of Epidemiologically Linked Cases of Lassa Fever
18. Comprehensive Characterization of Cellular Immune Responses Following Ebola Virus Infection
19. Passive Transfer of Animal-Derived Polyclonal Hyperimmune Antibodies Provides Protection of Mice from Lethal Lassa Virus Infection
20. Reply to Condello
21. Analysis of Diagnostic Findings From the European Mobile Laboratory in Guéckédou, Guinea, March 2014 Through March 2015
22. Streptococcal toxic shock syndrome with associated necrotising fasciitis necessitating amputation of the lower extremity – A case report.
23. Development of a Cost-effective Ovine Polyclonal Antibody-Based Product, EBOTAb, to Treat Ebola Virus Infection
24. Field Evaluation of Capillary Blood Samples as a Collection Specimen for the Rapid Diagnosis of Ebola Virus Infection During an Outbreak Emergency
25. Evidence for a Decrease in Transmission of Ebola Virus — Lofa County, Liberia, June 8–November 1, 2014
26. Familial acute aortic dissection associated with a novel ACTA2 germline variant
27. Automatic Layouting of Personalized Newspaper Pages
28. Determining the effect of different environmental conditions on Ebola virus viability in clinically relevant specimens
29. Unique human immune signature of Ebola virus disease in Guinea
30. Complement-Mediated Neutralisation Identified in Ebola Virus Disease Survivor Plasma: Implications for Protection and Pathogenesis
31. Temporal and spatial analysis of the 2014–2015 Ebola virus outbreak in West Africa
32. Primary and metastatic cardiac tumors: imaging characteristics, surgical treatment, and histopathological spectrum: a 10-year-experience at a German heart center
33. Lassa virus glycoprotein nanoparticles elicit a neutralizing antibody that defines a new site of vulnerability
34. Predictors and severity of intestinal ischaemia following on-pump cardiac surgery: a retrospective, propensity-matched analysis
35. Proteomic landscape of SARS-CoV-2– and MERS-CoV–infected primary human renal epithelial cells
36. Effects of Donor Pre-Treatment With Dopamine on Survival After Heart Transplantation: A Cohort Study of Heart Transplant Recipients Nested in a Randomized Controlled Multicenter Trial
37. Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe
38. A Monovalent Chimpanzee Adenovirus Ebola Vaccine Boosted with MVA
39. Effect of Artesunate–Amodiaquine on Mortality Related to Ebola Virus Disease
40. CP100356 Hydrochloride, a P-Glycoprotein Inhibitor, Inhibits Lassa Virus Entry: Implication of a Candidate Pan-Mammarenavirus Entry Inhibitor
41. Safety and immunogenicity of rVSV[DELTA]G-ZEBOV-GP Ebola vaccine in adults and children in Lambaréné, Gabon: A phase I randomised trial
42. Polymer microarrays rapidly identify competitive adsorbents of virus-like particles
43. Release of calcitonin gene-related peptide from the jugular–nodose ganglion complex in rats – A new model to examine the role of cardiac peptidergic and nitrergic innervation
44. Proteomic landscape of SARS-CoV-2- and MERSCoV-infected primary human renal epithelial cells.
45. Adjuvant formulated virus-like particles expressing native-like forms of the Lassa virus envelope surface glycoprotein are immunogenic and induce antibodies with broadly neutralizing activity
46. Polymer microarrays rapidly identify competitive adsorbents of virus-like particles (VLPs)
47. Visualization of a large ventricular aneurysm in a young man by 16-slice multi-detector row spiral computed tomography before successful surgical treatment
48. Polymer Microarrays Rapidly Identify Competitive Adsorbents of Virus-like Particles (VLPs)
49. Release of calcitonin gene-related peptide from the isolated mouse heart: Methodological validation of a new model
50. Exploring synergies between academia and vaccine manufacturers: a pilot study on how to rapidly produce vaccines to combat emerging pathogens
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.